The sphygmomanometer market size has grown strongly in recent years. It will grow from $2.98 billion in 2024 to $3.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to construction industry growth, agricultural sector demand, versatility and reach, infrastructure projects, efficiency in material handling, demand from rental market.
The sphygmomanometer market size is expected to see rapid growth in the next few years. It will grow to $4.84 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to renewable energy projects, urbanization and vertical construction, precision agriculture practices, focus on environmental sustainability, safety regulations compliance, global economic recovery. Major trends in the forecast period include product innovation, compact and maneuverable designs, electric and hybrid models, integration of telematics and iot, use of high-strength materials.
The anticipated growth in the sphygmomanometer market is driven by the increasing prevalence of chronic illnesses such as diabetes, hypertension, and ischemic heart disease. Chronic illnesses, characterized by their long-lasting nature, necessitate ongoing management and medical care. Sphygmomanometers play a crucial role in the management of these conditions, aiding in diagnosis, monitoring cardiovascular health, and identifying secondary causes of hypertension. For example, data from the Journal of the American College of Cardiology (JACC) in December 2022 revealed that ischemic heart disease alone accounted for 9.44 million cardiovascular deaths in 2021, with hypertensive heart disease and pulmonary arterial hypertension contributing to 1.41 million and 23,300 deaths, respectively. The rising prevalence of chronic illnesses underscores the importance of sphygmomanometers in healthcare, driving market growth.
The increasing number of ambulatory surgery centers is expected to contribute significantly to the growth of the sphygmomanometer market. Ambulatory Surgery Centers (ASCs), dedicated to performing surgical procedures without overnight hospital stays, heavily rely on sphygmomanometers (blood pressure cuffs) to monitor patients' vital signs throughout the surgical process. Recent data from VMG Health in September 2023 indicates a 2.9% increase in the total number of Medicare-certified ambulatory surgery centers, from 1752 in 2021 to 1804 in 2022. This growth in ambulatory surgery centers reflects an expanding healthcare landscape, driving the demand for sphygmomanometers in these facilities.
Major companies in the sphygmomanometer market are focusing on developing innovative products like automatic blood pressure monitors to enhance accuracy, improve user experience, and enable continuous monitoring of blood pressure for better management of hypertension and cardiovascular health. Automatic blood pressure monitors are electronic devices that measure blood pressure using an inflatable cuff and oscillometric technology, providing precise readings of systolic and diastolic pressures along with pulse rate for convenient self-monitoring at home. For example, in February 2022, InBody, a South Korea-based company specializing in body composition technology, launched the BP 170. This automatic blood pressure monitor is designed for home use and employs oscillometric technology to deliver accurate measurements of systolic and diastolic blood pressure as well as pulse rate. It features a user-friendly one-touch cuff for easy application, a large display for better visibility, and the ability to store readings for multiple users, making it suitable for family health monitoring. Furthermore, the device is clinically validated, ensuring reliable results that help users effectively manage their cardiovascular health.
Major companies in the sphygmomanometer market are actively engaged in developing innovative monitors, particularly at-home automatic blood pressure monitors, to gain a competitive edge. These devices allow individuals to measure blood pressure conveniently from the comfort of their homes. In February 2022, Inbody, a South Korea-based provider of health and wellness technology, introduced the InBody BP 170 at-home device. This clinically validated automatic blood pressure monitor enables users to measure systolic and diastolic blood pressure as well as pulse rate. The device utilizes an oscillometric technique to precisely monitor daily variations in pulse rate and blood pressure. The BP 170 can be connected to the InBody app via Bluetooth, enabling users to track blood pressure readings over time.
In November 2022, OMRON Healthcare, Co., Ltd., a Japan-based leader in healthcare technology, partnered with CardioSignal to advance early detection of cardiovascular disease and facilitate remote patient monitoring at scale. This collaboration aims to integrate CardioSignal’s innovative remote cardiac monitoring technology with OMRON Healthcare's existing product lineup, enhancing the ability to deliver real-time health insights for both patients and healthcare professionals. CardioSignal is a US-based company recognized for its mobile applications that enable the early detection of cardiovascular issues.
Major companies operating in the sphygmomanometer market include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Acoma Medical Industry Co. Ltd., Beurer GmbH, General Electric Company, Amico Group of Companies, CIGA Healthcare Ltd., HEINE Optotechnik GmbH and Co. KG, Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, 3B Scientific, Hill-Rom Services Inc., Sklar Surgical Instruments, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., Halma plc, SunTech Medical Inc.
North America was the largest region in the sphygmomanometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sphygmomanometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A sphygmomanometer is a device designed for measuring blood pressure, specifically the pressure in arteries. It comprises an inflatable cuff, which is used to restrict blood flow, and a gauge to measure the pressure.
The primary types of sphygmomanometers include electronic sphygmomanometers, aneroid sphygmomanometers, and mercury sphygmomanometers. An electronic sphygmomanometer is a medical device utilized for measuring blood pressure. It finds applications in clinical settings and is also suitable for self-monitoring of blood pressure at home. These electronic sphygmomanometers come in various configurations, including portable, desk-mounted, floor-standing, and wall-mounted options. They operate using electricity and may be manual, automatic, or semi-automatic. These devices are commonly employed in diverse healthcare settings such as hospitals, ambulatory surgical centers, clinics, home healthcare, and other end-user environments.
The sphygmomanometer market research report is one of a series of new reports that provides sphygmomanometer market statistics, including sphygmomanometer industry global market size, regional shares, competitors with a sphygmomanometer market share, detailed sphygmomanometer market segments, market trends and opportunities, and any further data you may need to thrive in the sphygmomanometer industry. This sphygmomanometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sphygmomanometer market consists of the sale of digital sphygmomanometers, portable sphygmomanometers, and hybrid sphygmomanometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The sphygmomanometer market size is expected to see rapid growth in the next few years. It will grow to $4.84 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to renewable energy projects, urbanization and vertical construction, precision agriculture practices, focus on environmental sustainability, safety regulations compliance, global economic recovery. Major trends in the forecast period include product innovation, compact and maneuverable designs, electric and hybrid models, integration of telematics and iot, use of high-strength materials.
The anticipated growth in the sphygmomanometer market is driven by the increasing prevalence of chronic illnesses such as diabetes, hypertension, and ischemic heart disease. Chronic illnesses, characterized by their long-lasting nature, necessitate ongoing management and medical care. Sphygmomanometers play a crucial role in the management of these conditions, aiding in diagnosis, monitoring cardiovascular health, and identifying secondary causes of hypertension. For example, data from the Journal of the American College of Cardiology (JACC) in December 2022 revealed that ischemic heart disease alone accounted for 9.44 million cardiovascular deaths in 2021, with hypertensive heart disease and pulmonary arterial hypertension contributing to 1.41 million and 23,300 deaths, respectively. The rising prevalence of chronic illnesses underscores the importance of sphygmomanometers in healthcare, driving market growth.
The increasing number of ambulatory surgery centers is expected to contribute significantly to the growth of the sphygmomanometer market. Ambulatory Surgery Centers (ASCs), dedicated to performing surgical procedures without overnight hospital stays, heavily rely on sphygmomanometers (blood pressure cuffs) to monitor patients' vital signs throughout the surgical process. Recent data from VMG Health in September 2023 indicates a 2.9% increase in the total number of Medicare-certified ambulatory surgery centers, from 1752 in 2021 to 1804 in 2022. This growth in ambulatory surgery centers reflects an expanding healthcare landscape, driving the demand for sphygmomanometers in these facilities.
Major companies in the sphygmomanometer market are focusing on developing innovative products like automatic blood pressure monitors to enhance accuracy, improve user experience, and enable continuous monitoring of blood pressure for better management of hypertension and cardiovascular health. Automatic blood pressure monitors are electronic devices that measure blood pressure using an inflatable cuff and oscillometric technology, providing precise readings of systolic and diastolic pressures along with pulse rate for convenient self-monitoring at home. For example, in February 2022, InBody, a South Korea-based company specializing in body composition technology, launched the BP 170. This automatic blood pressure monitor is designed for home use and employs oscillometric technology to deliver accurate measurements of systolic and diastolic blood pressure as well as pulse rate. It features a user-friendly one-touch cuff for easy application, a large display for better visibility, and the ability to store readings for multiple users, making it suitable for family health monitoring. Furthermore, the device is clinically validated, ensuring reliable results that help users effectively manage their cardiovascular health.
Major companies in the sphygmomanometer market are actively engaged in developing innovative monitors, particularly at-home automatic blood pressure monitors, to gain a competitive edge. These devices allow individuals to measure blood pressure conveniently from the comfort of their homes. In February 2022, Inbody, a South Korea-based provider of health and wellness technology, introduced the InBody BP 170 at-home device. This clinically validated automatic blood pressure monitor enables users to measure systolic and diastolic blood pressure as well as pulse rate. The device utilizes an oscillometric technique to precisely monitor daily variations in pulse rate and blood pressure. The BP 170 can be connected to the InBody app via Bluetooth, enabling users to track blood pressure readings over time.
In November 2022, OMRON Healthcare, Co., Ltd., a Japan-based leader in healthcare technology, partnered with CardioSignal to advance early detection of cardiovascular disease and facilitate remote patient monitoring at scale. This collaboration aims to integrate CardioSignal’s innovative remote cardiac monitoring technology with OMRON Healthcare's existing product lineup, enhancing the ability to deliver real-time health insights for both patients and healthcare professionals. CardioSignal is a US-based company recognized for its mobile applications that enable the early detection of cardiovascular issues.
Major companies operating in the sphygmomanometer market include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Acoma Medical Industry Co. Ltd., Beurer GmbH, General Electric Company, Amico Group of Companies, CIGA Healthcare Ltd., HEINE Optotechnik GmbH and Co. KG, Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, 3B Scientific, Hill-Rom Services Inc., Sklar Surgical Instruments, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., Halma plc, SunTech Medical Inc.
North America was the largest region in the sphygmomanometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sphygmomanometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A sphygmomanometer is a device designed for measuring blood pressure, specifically the pressure in arteries. It comprises an inflatable cuff, which is used to restrict blood flow, and a gauge to measure the pressure.
The primary types of sphygmomanometers include electronic sphygmomanometers, aneroid sphygmomanometers, and mercury sphygmomanometers. An electronic sphygmomanometer is a medical device utilized for measuring blood pressure. It finds applications in clinical settings and is also suitable for self-monitoring of blood pressure at home. These electronic sphygmomanometers come in various configurations, including portable, desk-mounted, floor-standing, and wall-mounted options. They operate using electricity and may be manual, automatic, or semi-automatic. These devices are commonly employed in diverse healthcare settings such as hospitals, ambulatory surgical centers, clinics, home healthcare, and other end-user environments.
The sphygmomanometer market research report is one of a series of new reports that provides sphygmomanometer market statistics, including sphygmomanometer industry global market size, regional shares, competitors with a sphygmomanometer market share, detailed sphygmomanometer market segments, market trends and opportunities, and any further data you may need to thrive in the sphygmomanometer industry. This sphygmomanometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sphygmomanometer market consists of the sale of digital sphygmomanometers, portable sphygmomanometers, and hybrid sphygmomanometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Sphygmomanometer Market Characteristics3. Sphygmomanometer Market Trends and Strategies4. Sphygmomanometer Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Sphygmomanometer Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Sphygmomanometer Market34. Recent Developments in the Sphygmomanometer Market
5. Global Sphygmomanometer Growth Analysis and Strategic Analysis Framework
6. Sphygmomanometer Market Segmentation
7. Sphygmomanometer Market Regional and Country Analysis
8. Asia-Pacific Sphygmomanometer Market
9. China Sphygmomanometer Market
10. India Sphygmomanometer Market
11. Japan Sphygmomanometer Market
12. Australia Sphygmomanometer Market
13. Indonesia Sphygmomanometer Market
14. South Korea Sphygmomanometer Market
15. Western Europe Sphygmomanometer Market
16. UK Sphygmomanometer Market
17. Germany Sphygmomanometer Market
18. France Sphygmomanometer Market
19. Italy Sphygmomanometer Market
20. Spain Sphygmomanometer Market
21. Eastern Europe Sphygmomanometer Market
22. Russia Sphygmomanometer Market
23. North America Sphygmomanometer Market
24. USA Sphygmomanometer Market
25. Canada Sphygmomanometer Market
26. South America Sphygmomanometer Market
27. Brazil Sphygmomanometer Market
28. Middle East Sphygmomanometer Market
29. Africa Sphygmomanometer Market
30. Sphygmomanometer Market Competitive Landscape and Company Profiles
31. Sphygmomanometer Market Other Major and Innovative Companies
35. Sphygmomanometer Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Sphygmomanometer Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on sphygmomanometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sphygmomanometer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sphygmomanometer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Electronic Sphygmomanometer; Aneroid Sphygmomanometer; Mercury Sphygmomanometer2) By Configuration: Portable; Desk Mounted; Floor Standing; Wall Mounted
3) By Operation: Electric; Manual; Automatic; Semi-automatic
4) By End User: Hospitals; Ambulatory Surgical Centers and Clinics; Home Healthcare; Other End Users
Subsegments:
1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer; Wrist Electronic Sphygmomanometer; Finger Electronic Sphygmomanometer2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer; Digital Aneroid Sphygmomanometer
3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer; Portable Mercury Sphygmomanometer
Key Companies Mentioned: A&D Company Ltd.; American Diagnostic Corporation; Omron Healthcare Inc.; Microlife Corporation; Acoma Medical Industry Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Sphygmomanometer market report include:- A&D Company Ltd.
- American Diagnostic Corporation
- Omron Healthcare Inc.
- Microlife Corporation
- Acoma Medical Industry Co. Ltd.
- Beurer GmbH
- General Electric Company
- Amico Group of Companies
- CIGA Healthcare Ltd.
- HEINE Optotechnik GmbH and Co. KG
- Rossmax International Ltd.
- Rudolf Riester GmbH
- Welch Allyn Inc.
- Koninklijke Philips N.V.
- Paul Hartmann AG
- 3B Scientific
- Hill-Rom Services Inc.
- Sklar Surgical Instruments
- Spengler
- Holtex Ltd.
- Timesco Healthcare Ltd.
- Bremed Ltd.
- iHealth Labs Inc.
- Contec Medical Systems Co. Ltd.
- Halma plc
- SunTech Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 3.22 Billion |
| Forecasted Market Value ( USD | $ 4.84 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
